Michael Chambers

Michael Chambers is the co-founder of Aldevron, a company that provides nucleic acids, proteins, enzymes, and other biologicals to business partners in the biosciences sector, in 1998 and was President and Chief Executive Officer until August 2020 and served as Executive Chairman until August 2021 when Aldevron was acquired by Danaher Corporation. Chambers has been a member of the Board of Sarepta therapeutics since June 2022, also serving as a member of the research and development committee. Beginning in August 2020, Chambers has served as a member of the board of directors of Calviri Inc, an integrated oncology company focused on cancer diagnostics and preventative cancer vaccines. Chambers has also served on the board of directors of Agathos Biologics since 2020. Chambers holds a Bachelor of Science degree in Biotechnology, Microbiology and Chemistry from North Dakota State University.